Disclosed herein is a table comprising a first layer and a second layer wherein The first layer comprises a compound of formula I (elvitegravir) and a compound of formula II (cobicistat) and optionally a pharmaceutically acceptable carrier and The second layer comprises a compound of formula III (emtricitabine) and a salt of formula IV (tenofovir) and optionally a pharmaceutically acceptable carrier.